Is Paychex Stock About To Rebound?
For questions about this article or underlying research, email help@trefis.com.
Paychex (PAYX) stock has returned to the price zone where it bounced in late 2023 and mid-2024, along with a separate bounce in January 2024. The shares closed at $118.71 on November 4, 2026. This sits below the stock’s highest close of the past year, which was $127.34 on August 31. Investors banking on a repeat bounce are counting on two things. They need Paychex’s PEO business, where revenue tracks the number of covered client workers, to continue outgrowing the rest of the company. They also need the company’s margin to keep widening. What did Paychex shares do the last times they stood here?
How Far Has Paychex Bounced From This Price Before?
The stock bounced from this zone three times across 2023 and 2024. Shares purchased on November 30, 2023, January 19, 2024 and July 15, 2024 gained between 21.8% and 31.4% at their peak within a year. More recent visits moved in the opposite direction. Since October 31, 2024, Paychex dropped into this territory twice, specifically on October 1, 2025 and August 14, 2026. On both occasions, the stock fell 5% before it could rise 20%. The stock fell 8.8% on September 23, the day of the earnings call. The stock has returned 18.7% since October 6, climbing back into this zone from below.
Past rallies stalled twice before at $147.99. If the stock climbs back to that mark, $10,000 invested today would be worth about $12,470. Following a typical historical bounce, the same $10,000 would be worth about $12,190. This means Paychex would have to rise more than it usually did to get that far. Other past rallies stalled lower, at $127.97 and $141.73.
| Level | Price | From today |
|---|---|---|
| Resistance: rallies stalled here 2 times | $147.99 | 24.7% higher |
| Today | $118.71 | Reference price |
| Support is broken below | $112.77 | 5.0% lower |
| Next support below | $108.60 | 8.5% lower |
Paychex’s PEO Business Is Still Growing Faster
PEO and insurance revenue rose 12% in fiscal Q1 2027, the quarter ending August 31, 2026. This outpaced the 4% growth reported for the larger Management Solutions business, management said on the September 23 call. Management also raised the fiscal 2027 PEO and insurance growth forecast to 7.5% at the midpoint, up from 6.5%, citing continued strength in PEO.
Overall growth has slowed anyway. Paychex’s revenue grew 5.9% in fiscal Q1 2027, down from 12.5% in the prior quarter. Most of that revenue still comes from Management Solutions, which accounted for $1.2 billion of the quarter’s $1.6 billion total.
Is Paychex’s Margin Still Widening?
Compared with a year earlier, yes. Paychex’s operating margin rose to 38.0% in fiscal Q1 2027, up from 35.2% a year before. Management said total expenses rose just 1%, as AI efficiencies and lower acquisition costs largely offset higher PEO insurance costs.
Measured over twelve months, the 39.2% margin is up from 38.0% a year earlier. It remains below the 41.1% recorded for the twelve months to August 2024. By its own standards, the stock is not expensive. Paychex trades at 23.4 times its trailing earnings. This multiple sits toward the low end of the 18.7 to 36.2 times range it traded at across quarter-ends since fiscal 2017.
Where Paychex’s Next Support Lies If This Zone Breaks
The next support level sits at $108.60, which is 8.5% under today’s price. The stock already closed below both levels for several weeks after the September 23 call, before climbing back into this zone. The current zone counts as broken if the stock falls below $112.77. Management’s outlook offers a reason for caution. Management expects revenue growth of about 4% in fiscal Q2 2027, compared with a year-earlier quarter that included two one-time items. Management also said PEO comparisons get harder over the rest of the year. They added the company was being conservative because two big enrollment periods, in October and January, still lay ahead.
What Should Paychex Investors Watch In December?
Paychex’s PEO business is still outgrowing the rest of the company, and its margin is wider than a year ago. Between these two trends, PEO growth is the less settled metric. PEO and insurance revenue growth for fiscal Q2 2027 is the number to watch when Paychex reports in December 2026.
Still Holding Paychex After The Drop?
Selling a fallen stock can still bring a tax bill if you bought long ago, and holding keeps the risk. A free 30-minute strategy review with our partner advisory firm covers a floor under a large position and a lower-tax unwind.
Spot an error or want more like this? Tell us in 10 seconds.